Summit Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 11/14/2024 | 24.42 M | $534.90 M | 5.18% | 3.36% |
| VANGUARD GROUP INC | 11/13/2024 | 10.95 M | $239.73 M | 24.13% | 1.51% |
| FMR LLC | 11/13/2024 | 8.30 M | $181.84 M | 9.75% | 1.14% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 8.09 M | $177.27 M | 100.00% | 1.11% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 5.44 M | $119.13 M | 166.38% | 0.75% |
| STATE STREET CORP | 11/14/2024 | 3.47 M | $75.96 M | -15.88% | 0.48% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.10 M | $67.90 M | 4.59% | 0.43% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.43 M | $31.38 M | 53.28% | 0.20% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.22 M | $26.77 M | -37.09% | 0.17% |
| ABRDN PLC | 10/25/2024 | 1.14 M | $24.88 M | 100.00% | 0.16% |
| DARWIN GLOBAL MANAGEMENT, LTD. | 11/14/2024 | 1.08 M | $23.76 M | 100.00% | 0.15% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.04 M | $22.78 M | 100.00% | 0.14% |
| TWIN TREE MANAGEMENT, LP | 11/13/2024 | 890,500 | $19.50 M | 100.00% | 0.12% |
| CANDRIAM S.C.A. | 11/13/2024 | 850,403 | $18.62 M | 100.00% | 0.12% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 694,722 | $14.51 M | 160.39% | 0.10% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 691,404 | $14.44 M | -2.43% | 0.10% |
| JANE STREET GROUP, LLC | 11/15/2024 | 684,300 | $14.99 M | 100.00% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2024 | 650,833 | $14.25 M | 100.00% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 611,100 | $13.38 M | 349.01% | 0.08% |
| MORGAN STANLEY | 11/14/2024 | 577,298 | $12.64 M | 71.25% | 0.08% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 495,355 | $10.85 M | 9.12% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 485,200 | $10.63 M | 47.84% | 0.07% |
| CITADEL ADVISORS LLC | 11/14/2024 | 457,800 | $10.03 M | 598.93% | 0.06% |
| JANE STREET GROUP, LLC | 11/15/2024 | 450,500 | $9.87 M | 100.00% | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 431,176 | $9.44 M | -57.32% | 0.06% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 422,950 | $9.26 M | -46.33% | 0.06% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 402,167 | $8.81 M | 1,254.10% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 390,660 | $8.56 M | 14.51% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 366,395 | $8.02 M | 44.36% | 0.05% |
| QVT FINANCIAL LP | 11/14/2024 | 360,524 | $7.90 M | -37.38% | 0.05% |
| JANE STREET GROUP, LLC | 11/15/2024 | 351,151 | $7.69 M | 86.94% | 0.05% |
| CITADEL ADVISORS LLC | 11/14/2024 | 327,400 | $7.17 M | 127.68% | 0.05% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 295,629 | $6.47 M | 43.47% | 0.04% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 285,000 | $6.24 M | 100.00% | 0.04% |
| E FUND MANAGEMENT CO., LTD. | 11/13/2024 | 281,105 | $6.16 M | 2,689.85% | 0.04% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 269,755 | $5.91 M | -2.51% | 0.04% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 257,531 | $5.64 M | 0.19% | 0.04% |
| BARCLAYS PLC | 11/19/2024 | 250,118 | $5.48 M | -35.42% | 0.03% |
| BOXER CAPITAL, LLC | 11/14/2024 | 250,000 | $5.48 M | 100.00% | 0.03% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 249,393 | $5.46 M | -11.05% | 0.03% |
| TWIN TREE MANAGEMENT, LP | 11/13/2024 | 223,826 | $4.90 M | 47,421.44% | 0.03% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 186,918 | $4.09 M | 100.00% | 0.03% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 168,094 | $3.68 M | 19.57% | 0.02% |
| JPMORGAN CHASE & CO | 11/08/2024 | 162,649 | $3.56 M | -0.67% | 0.02% |
| WOLVERINE TRADING, LLC | 11/14/2024 | 154,700 | $3.23 M | 1,118.11% | 0.02% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 140,000 | $3.07 M | 100.00% | 0.02% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 10/25/2024 | 139,352 | $3.05 M | 68.97% | 0.02% |
| WOLVERINE TRADING, LLC | 11/14/2024 | 137,600 | $2.87 M | 319.51% | 0.02% |
| FORA CAPITAL, LLC | 11/13/2024 | 128,894 | $2.82 M | 100.00% | 0.02% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 126,098 | $2.76 M | 100.00% | 0.02% |
Summit Therapeutics Inc.institutional Ownership - FAQ's
During the previous two years, 183 institutional investors and hedge funds held shares of Summit Therapeutics Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 24.42 M
VANGUARD GROUP INC: 10.95 M
FMR LLC: 8.3 M
BlackRock Funding, Inc. /DE: 8.09 M
PRICE T ROWE ASSOCIATES INC /MD/: 5.44 M
STATE STREET CORP: 3.47 M
11.62% of Summit Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 96.25 M shares in the last 24 months. This purchase volume represents approximately $1.72 B in transactions.